Group B streptococcal necrotizing pneumonia in a diabetic adult patient.

Group B streptococcal necrotizing pneumonia in a diabetic adult patient. Rev Argent Microbiol. 2017 Mar 18;: Authors: Pacha A, Luna Cian R, Bonofiglio L, Solari M, Strada V, Suárez M, Vigliarolo L, Tersigni C, Mollerach M, Lopardo H Abstract The aim of this report is to describe a rare case of necrotizing pneumonia due to group B Streptococcus serotype III in a relatively young male adult (48 years old) suffering from diabetes. The organism was isolated from his pleural fluid and was only resistant to tetracycline. The patient first received ceftazidime (2g/8h i.v.)+clindamycin (300mg/8h) for 18 days and then he was discharged home and orally treated with amoxicillin clavulanic acid (1g/12h) for 23 days with an uneventful evolution. As in the cases of invasive infection by Streptococcus pyogenes, clindamycin could prevent streptococcal toxic shock syndrome. PMID: 28325626 [PubMed - as supplied by publisher]
Source: Revista Argentina de Microbiologia - Category: Microbiology Tags: Rev Argent Microbiol Source Type: research